Somatically, MITF gene fusions have been reported in RCC [130, 131], while MITF amplification is common in melanoma [132, 133] and aberrant MITF transcription is responsible for the oncogenic transformation of clear cell sarcoma subtypes [134]. Here, MITF is linked to renal cell carcinoma.